Hormone News and Research

RSS

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. It is essentially a chemical messenger that transports a signal from one cell to another.

New drug combination shows promise in treating men with metastatic prostate cancer

A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.

26 Nov 2015

Researchers begin landmark clinical study to restore normal insulin secretion in people with type 1 diabetes

Investigators at Montreal's Lady Davis Institute at the Jewish General Hospital and McGill University Health Centre have announced the start of a landmark clinical study aimed at restoring normal insulin secretion in people with longstanding type 1 diabetes.

26 Nov 2015

Purdue researchers develop products and processes to improve detection, treatment of diabetes

Food gatherings at Thanksgiving and Christmas require rigorous management by people affected by diabetes. Type 1 diabetes, also known as juvenile diabetes, is the result of the breakdown of insulin-producing cells in the pancreas. Type 2 diabetes can be the result of a combination of obesity, high caloric intake and a sedentary lifestyle.

26 Nov 2015

TransLUMINAL-B project kicked off to study luminal breast cancers

Following a kick-off meeting, the TransLUMINAL-B project, which is being led by Charité -- Universitätsmedizin Berlin, is now officially underway. Over the next three years, researchers involved in the project will study the process of metastasis formation and the role of malignant cells, which accumulate in the blood and bone marrow of patients with certain types of breast cancer.

26 Nov 2015

New sensor can detect estrogen levels in liquids

Estrogen is a tiny molecule, but it can have big effects on humans and other animals. Estrogen is one of the main hormones that regulates the female reproductive system - it can be monitored to track human fertility and is sometimes administered to livestock like cows and sheep to control the reproductive cycle.

25 Nov 2015

Health insurance coverage for transgender people is cost-effective, study finds

A new analysis led by the Johns Hopkins Bloomberg School of Public Health suggests that while most U.S. health insurance plans deny benefits to transgender men and women for medical care necessary to transition to the opposite sex, paying for sex reassignment surgery and hormones is actually cost-effective.

25 Nov 2015

Women with moderate-to-severe PMS at increased risk of developing high blood pressure in later life

In the first prospective study to consider premenstrual syndrome (PMS) as a possible sentinel for future risk of hypertension, epidemiologist Elizabeth Bertone-Johnson and colleagues in the School of Public Health and Health Sciences at the University of Massachusetts Amherst and the Harvard School of Public Health report that women with moderate-to-severe PMS had a 40 percent higher risk of developing high blood pressure over the following 20 years compared to women experiencing few menstrual symptoms.

25 Nov 2015

More hormone treatments decrease women's chances of having baby

A Michigan State University study has found that too much of a hormone commonly used during in vitro fertility, or IVF, treatments actually decreases a woman's chances of having a baby.

24 Nov 2015

Finding may lead to better understanding of male genital birth defects

University of Florida Health researchers have identified genes that are disrupted by abnormal hormone signaling at crucial points during development, a finding that may lead to a better understanding of how the most common male genital birth defects arise in humans.

24 Nov 2015

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

23 Nov 2015

Men with prostate cancer get stronger bones from playing football

Men with prostate cancer run the risk of brittle bones as a side-effect of their treatment. But one hour's football training a few times a week counters many of the negative effects of the treatment, according to University of Copenhagen scientists.

23 Nov 2015

Mason researchers patent new breast cancer treatment

George Mason University researchers have patented a new breast cancer treatment that uses a common malaria drug to stop cancer in its beginning stages.

21 Nov 2015

NICE recommends Xofigo (radium-223 dichloride) for patients with advanced prostate cancer

The National Institute for Health and Care Excellence today issued its Final Appraisal Determination (FAD) recommending Xofigo (radium-223 dichloride) for use on the NHS in England as an option for treating adult men, with hormone-relapsed prostate cancer, symptomatic bone metastases and no known visceral metastases, who have received previous docetaxel therapy.

20 Nov 2015

Interaction between two brain proteins has substantial effect on memory formation

In a new study that could have implications for future drug discovery efforts for a number of neurodegenerative diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that the interaction between a pair of brain proteins has a substantial and previously unrecognized effect on memory formation.

20 Nov 2015

New injectable 'biogel' may become new weapon against cancer

A new injectable "biogel" is effective in delivering anti-cancer agents directly into cancerous tumours and killing them. This technology, developed by researchers at the University of Montreal Hospital Research Centre, has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionize treatment for many forms of cancer.

20 Nov 2015

WSU researchers establish categorical distinction between heterosexuals and non-heterosexuals

Washington State University researchers have established a categorical distinction between people who are heterosexual and those who are not. By analyzing the reported sexual behavior, identity and attraction of more than 33,000 American adults, they found that 3 percent of men and 2.7 percent of women are not heterosexual. They also found notable issues on several mental health fronts.

20 Nov 2015

Urine-derived iPSCs model could help predict patient response to cholesterol-lowering drugs

We all know how important it is to keep our levels of blood cholesterol - especially the 'bad' variety - in check with a healthy diet and regular exercise. Although cholesterol is a key structural component of cell membranes and is vital for the biosynthesis of certain hormones and vitamins, high levels can lead to the formation of arterial plaques, which are a major risk factor for coronary heart disease.

20 Nov 2015

Lilly, Merck expand oncology clinical trial collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced the extension of an existing collaboration to evaluate the safety and efficacy of the combination of Lilly's ALIMTA (pemetrexed for injection) and Merck's KEYTRUDA (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC).

19 Nov 2015

Testosterone cause of sex differences in the occurrence of Parkinson’s disease, new research suggests

Men are twice as likely as women to develop Parkinson's disease, a nervous system disorder characterized by tremors and difficulty moving. New research to be presented at Cardiovascular, Renal and Metabolic Diseases: Physiology and Gender suggests that the difference in risk may be due to the presence of the male sex hormone testosterone.

19 Nov 2015

New insulin pill shows promise as novel form of therapy for diabetes

An insulin pill being developed by researchers at UC Santa Barbara may in the near future give another blood sugar management option to those who suffer from diabetes. The novel drug delivery technology may also apply to a wide spectrum of other therapies.

19 Nov 2015

Hormone News and Research

Further Reading

New drug combination shows promise in treating men with metastatic prostate cancer

Researchers begin landmark clinical study to restore normal insulin secretion in people with type 1 diabetes

Purdue researchers develop products and processes to improve detection, treatment of diabetes

TransLUMINAL-B project kicked off to study luminal breast cancers

New sensor can detect estrogen levels in liquids

Health insurance coverage for transgender people is cost-effective, study finds

Women with moderate-to-severe PMS at increased risk of developing high blood pressure in later life

More hormone treatments decrease women's chances of having baby

Finding may lead to better understanding of male genital birth defects

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

Men with prostate cancer get stronger bones from playing football

Mason researchers patent new breast cancer treatment

NICE recommends Xofigo (radium-223 dichloride) for patients with advanced prostate cancer

Interaction between two brain proteins has substantial effect on memory formation

New injectable 'biogel' may become new weapon against cancer

WSU researchers establish categorical distinction between heterosexuals and non-heterosexuals

Urine-derived iPSCs model could help predict patient response to cholesterol-lowering drugs

Lilly, Merck expand oncology clinical trial collaboration

Testosterone cause of sex differences in the occurrence of Parkinson’s disease, new research suggests

New insulin pill shows promise as novel form of therapy for diabetes

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News